Condition
Neoadjuvant Immunochemotherapy clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Neoadjuvant Immunochemotherapy clinical trials that are recruiting, in China. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 1Country
Newest Neoadjuvant Immunochemotherapy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Tafolecimab with chemoimmunotherapy as neoadjuvant treatment for locally advanced colon cancer | Phase 2 | Chongqing, Chongqing Municipality | Recruiting | Sep 25, 2026 |
| Using AI on CT scans to predict complete response in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy | — | Wuhan, Hubei | Recruiting | Jul 28, 2025 |
| Surufatinib with chemo-immunotherapy and chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma | Phase 2 | Guangzhou, Guangdong | Recruiting | Jul 25, 2025 |
All recruiting trials (3)
-
Tafolecimab with chemoimmunotherapy as neoadjuvant treatment for locally advanced colon cancer
This study tests whether adding tafolecimab to a chemoimmunotherapy regimen helps shrink locally advanced colon cancer before surgery in adults who have pMMR/MSS tumors.
-
Using AI on CT scans to predict complete response in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy
This project will test whether a deep-learning model using chest CT images and clinical data can predict which esophageal squamous cell carcinoma patients will have a complete pathological response after neoadjuvant immunochemotherapy.
-
Surufatinib with chemo-immunotherapy and chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma
This trial will test whether adding surufatinib to two cycles of chemo-immunotherapy followed by concurrent chemoradiotherapy helps people with unresectable, locally advanced esophageal squamous cell carcinoma.
Related topics
Quick answers
How many Neoadjuvant Immunochemotherapy clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.